PTHS CIK: 1919246

Pelthos Therapeutics Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY22
FY23
FY24
FY25
FY22 – FY25

Assets

(positive)
Change from FY22 to FY25
millions USD
FY22:
0.06
FY23:
0.10
FY24:
1.37
FY25:
53.4
(positive)
millions USD
FY22:
0
FY23:
0
FY24:
0
FY25:
77.0
Total assets
Change from FY22 to FY25
millions USD
FY22:
0.06
FY23:
0.10
FY24:
1.37
FY25:
130

Liabilities & Equity

(negative)
Change from FY22 to FY25
millions USD
FY22:
3.76
FY23:
6.54
FY24:
4.08
FY25:
26.0
(negative)
millions USD
FY22:
0
FY23:
0
FY24:
0
FY25:
65.5
(positive)
Change from FY22 to FY25
millions USD
FY22:
−3.71
FY23:
−6.44
FY24:
−2.71
FY25:
38.9
Total liabilities & equity
Change from FY22 to FY25
millions USD
FY22:
0.06
FY23:
0.10
FY24:
1.37
FY25:
130

All amounts in millions USD Data source:SEC EDGAR